NeuroOne Introduces Advisory Board for Ablation Electrode Technology that Records and Ablates Brain Tissue Linked to Seizure Activity

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC; NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today the formation of a six member advisory board of leading neurosurgeons to assist in the completion of development of a radio frequency ablation electrode intended to record and ablate brain tissue linked to causing seizure activity.

Related Keywords

,Neuroone Medical Technologies Corporation ,The Company ,Radio Frequency Ablation ,Company ,Brain Tissue ,Mayo Clinic ,George Washington University ,Neurological Disorders ,Euro One ,Columbia University ,Emory University ,Technology ,Zimmer Biomet ,யூரோ ஒன்று ,